Aveo Pharmaceuticals to pay U.S. SEC $4 mln to settle kidney drug case

March 29 (Reuters) - Biotech company Aveo Pharmaceuticals

Inc will pay $4 million to settle civil charges that it

misled investors about U.S. regulators' concerns involving its

drug to treat kidney...

Read more